Chinese scientist He Jiankui spent three years in prison after 'creating' three genetically edited babies. Back in the ...
Key opportunities in the gene therapy market include treating genetic disorders and cancer, driven by rising FDA approvals and biotechnological advancements. The in vivo segment, cancer treatments, ...
CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic diseases, enhancing crops, and engineering ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Imviva Biotech's CTD402 to accelerate the ...
Key takeawaysTau is the most common protein that aggregates in neurodegeneration diseases. However, researchers had not ...
The South Dakota House of Representatives approved a bill to declare cultivated protein products or fake meat as “adulterated ...
Brevard is releasing sterilized male mosquitoes to combat dengue fever, Zika and other mosquito-borne illnesses.
Researchers identified AlCas12a, a compact, versatile enzyme that improves CRISPR gene editing and enables faster molecular ...
Some scientists who argue for deregulation deny outdoor gene editing is possible. But patents and the scientific literature tell a very different story. Report: Claire Robinson ...
Non-specific Endonuclease Market to reach US$ 726.6 Bn by 2036 at 6.5% CAGR, driven by rising biotechnology research, ...
Quince Therapeutics’ novel method of delivering steroids in a patient’s own red blood cells has turned out to be a bust in ataxia-telangiectasia (A-T), a rare inherited disorder. | Quince Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results